FULC Fulcrum Therapeutics Inc

USD 3.56 -0.08 ( -2.20)%
Icon

Fulcrum Therapeutics Inc (FULC) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.56

-0.08 (-2.20)%

N/A

0.87M

USD 10.70(+200.56%)

USD 9.33 (+162.08%)

Icon

FULC

Fulcrum Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 3.56
-0.08 ( -2.20)%

Fulcrum Therapeutics Inc (FULC) Stock Forecast

Show ratings and price targets of :
USD 10.70
(+200.56%)

Based on the Fulcrum Therapeutics Inc stock forecast from 7 analysts, the average analyst target price for Fulcrum Therapeutics Inc is USD 10.70 over the next 12 months. Fulcrum Therapeutics Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Fulcrum Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, Fulcrum Therapeutics Inc’s stock price was USD 3.56. Fulcrum Therapeutics Inc’s stock price has changed by +3.79% over the past week, +2.30% over the past month and +2.59% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...